ÂÜÀòÉç

Important update on event submissions and edits 01-May-2024
We are currently transitioning to a new RSC events submission system and website.
• New event submissions may take up to one week to be published while we complete the transition.
• Editing existing events is temporarily unavailable. New edit links will be issued next week.
Your patience is appreciated while we finalise these improvements to the RSC events website.
If you have any questions, please contact the Events Database Team eventsdatabase@rsc.org

Cardiovascular Safety and State-of-the-art Development Issues: Type 2 Diabetes Mellitus Medications, QT, Benefit/Risk Assessment, Arrhythmias, Thrombosis, and Cardiotoxicity

17 - 18 April 2012, Washington, DC, United States


Introduction
Join Industry Experts and Regulators to Improve Your Safety Analysis During Drug Development, Analyze and Mitigate Potential Risks, and Explore New Solutions and Approaches to Developing Safe and Effective Medications, including those to treat Type 2 Diabetes Mellitus.

Event Code:
12009

Useful links

Venue
Washington Marriott Hotel

Washington Marriott Hotel, Washington, DC, 20037, United States

Organised by
DIA
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*